TrialJAMA neurology2020
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial.
Paula R Clemens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
168 papers cite itlatest 60 shown
this paperpooled ittrialcites it